Terns Pharmaceuticals (TERN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

TERN Terns Pharmaceuticals

Watchlist

7.250
+0.530+7.89%

Close Aug 16 16:00 ET

7.240
-0.010-0.14%

Post 20:02 ET

510.20MMarket Cap-5492P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Watching Shares Of Terns Pharmaceuticals; Traders Circulating Popular Newsletter Positively Mentioning The Company
BenzingaAug 15 11:57 ET
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Announces Target Price $10
Moomoo NewsAug 7 02:32 ET · Ratings
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $15
Moomoo NewsAug 7 01:32 ET · Ratings
Buy Rating for Terns Pharmaceuticals Amid Forthcoming Milestones and Financial Stability
TipRanksAug 7 00:36 ET · Ratings
Terns Pharma Analyst Ratings
BenzingaAug 6 09:51 ET · Ratings
TD Cowen Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating
Moomoo NewsAug 6 08:31 ET · Ratings

Comments

frogoracletrading

Jul 11 08:52

$TERN Support / Resistance Levels

Finally over that 8.30 level that has been rejecting in the past. Here are the extended levels to watch.
Larger Image: tradingview.com...
$Terns Pharmaceuticals (TERN.US)$

Jaguar8

Jun 21 17:31

NEWS

$Terns Pharmaceuticals (TERN.US)$
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
Terns Pharmaceuticals announced new preclinical data supporting their compound TERN-501 in combination with a GLP-1 receptor agonist for treating obesity. The data was presented at the ADA’s 84th Annual Scientific Sessions. TERN-501, a highly selective THR-...